Glucuronolactone - Besremi (Ropeginterferon alfa-2b-njft) Interaction
Herbal: Glucuronolactone
Drug: Ropeginterferon alfa-2b-njft
Brand names:
Besremi

Medical Content Editor Dr. Brian Staiger, PharmD
Last updated
May 04, 2025
Interaction Details
There were no interactions found between Ropeginterferon alfa-2b-njft and Glucuronolactone. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Ropeginterferon alfa-2b-njft Overview
-
Ropeginterferon alfa-2b injection is used to treat polycythemia vera (PV; a slow growing cancer of the blood in which the bone marrow makes too many red blood cells). Ropeginterferon alfa-2b injection is in a class of medications called interferons. It works by blocking the signals that cause cancer cells to multiply.
Glucuronolactone - More Interactions
Glucuronolactone interacts with 0 drugs
Interaction Rating Key
These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.
Major | The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur. |
Moderate | Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur. |
Minor | Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction. |
Unknown | No interactions have been reported or no interaction data is currently available. |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.